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Abstract
Salmonella enterica serovar Heidelberg ranks among the most prevalent causes of human 
salmonellosis in the United States and Canada, although it has been infrequently reported 
in South American and European countries. Most Salmonella infections are self-limiting; 
however, some invasive infections require antimicrobial therapy. In this work we 
characterized an oxyimino-cephalosporin resistant S. Heidelberg isolate recovered from 
an inpatient in a Buenos Aires hospital. CMY-2 was responsible for the β-lactam resistance 
profi le. S. Heidelberg contained a 97 kb plasmid belonging to the Inc N group harboring 
blaCMY-2. ISEcp1 was located upstream blaCMY-2 driving its expression and mobilization. The 
isolate belonged to sequence type 15 and virotyping revealed the presence of sopE gene. 
In this study we identifi ed the fi rst CMY-2 producing isolate of S. Heidelberg in Argentina 
and even in South America. 
© 2014 Asociación Argentina de Microbiología. Published by Elsevier España, S.L. All 
rights reserved.
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Resumen
Salmonella enterica serovar Heidelberg es uno de los principales agentes causantes de 
salmonelosis en humanos en Estados Unidos y Canadá, sin embargo, resulta infrecuente 
en los países de Sudamérica y Europa. En este trabajo se caracterizó un aislamiento de 
S. Heidelberg resistente a oximino-cefalosporinas recuperado de un paciente internado 
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Salmonella enterica serovar Heidelberg is the causative 
agent of salmonellosis, a self-limiting gastroenteritis that 
does not usually require antibiotic therapy. However, seve-
re infections may occur, particularly in children and immu-
nocompromised hosts, leading to invasive diseases that re-
quire antimicrobial treatment. Fluoroquinolones and 
extended-spectrum cephalosporins are frequently used in 
severe Salmonella infections10.
Since the late ‘80s Salmonella isolates displaying 
resistance to extended spectrum cephalosporins have 
emerged worldwide. Coding genes for TEM-, SHV-, PSE-, 
OXA-, PER-, CTX-M-, CMY-, ACC-, DHA- extended spectrum 
β-lactamases (ESBL) and also KPC carbapenemases have 
been reported in S. enterica isolates9,14.
S. enterica serovar Heidelberg ranks among the most 
prevalent causes of human salmonellosis in the United 
States and Canada, although it is infrequently reported in 
South American and European countries1,8,9. During the last 
decade, extended-spectrum cephalosporin resistance has 
increased among human and agri-food isolates of this 
serotype in North American countries. This resistance 
profi le is mainly associated with the spread of blaCMY-2 
plasmid encoded AmpC β-lactamase10. S. Heidelberg is also 
one of the most common Salmonella serovars isolated from 
poultry and eggs, whose consumption has led to many 
foodborne infection outbreaks. Infections caused by person-
 to-person transmission or direct contact with infected 
animals have been rarely reported7.
In Argentina, S. Heidelber g isolates are very infrequent 
among those submitted to the Centro Nacional de Referencia 
(Mariana Pichel- Instituto Nacional de Enfermedades Infec-
ciosas-ANLIS “Carlos G. Malbrán”- personal communication). 
In this study, we characterized oxyimino-cephalosporin 
resistance in an S. Heidelberg isolate recovered from a 
diarrheal stool sample of an HIV adult inpatient, in February 
2012, in Buenos Aires. Identifi cation was carried out using 
conventional culture methods. Serotyping was conducted at 
the Centro Nacional de Salmonella (CNS) in Montevideo, 
Uruguay. The CNS, housed in the Departamento de 
Bacteriología y Virología, Instituto de Higiene, Universidad 
de la República, has characterized Salmonella isolates of 
human, animal, food, feed and environmental origin, 
voluntarily submitted by several private and public 
laboratories for the last 60 years in Uruguay.
Minimal Inhibitory Concentrations (MICs) of different an-
timicrobial agents were determined using broth microdilu-
tion testing and interpreted according to the Clinical and 
Laboratory Standards Institute (CLSI) guidelines5. S. Heidel-
berg was resistant to ampicillin, cephalothin, cefoxitin, ce-
ftriaxone, ceftazidime, intermediate to tetracycline and 
susceptible to cefepime, imipenem, aztreonam, kanamy-
cin, gentamicin, ciprofl oxacin, levofl oxacin and cloramphe-
nicol. Phenotypic screening for β-lactamases was perfor-
med by synergy tests using amoxicillin/clavulanic acid (10 
μg/10 μg) and phenyl-boronic acid (300 μg)-containing 
disks. Synergy was observed between phenyl-boronic acid 
and both ceftazidime and cefotaxime disks, suggesting the 
presence of an AmpC type β-lactamase. Plasmid DNA was 
purifi ed according to the Kado and Liu method. A multiplex-
PCR assay was conducted to reveal the presence of plasmid-
encoded ampC alleles15, rendering a 462 bp amplicon, which 
suggested the presence of a coding gene for a CIT cluster 
β-lactamase. The following specifi c primers (5´- 3´) were 
used to achieve the complete blaCMY gene: CMY-F: ATGATGA-
AAAAATCGTTATGCT and CMY-R: TTATTGCAGCTTTTCAAGA-
ATGCG. The nucleotide sequence of the 1140 bp amplicon 
obtained corresponded to blaCMY-2. The genetic context of 
blaCMY-2 was determined by PCR mapping and sequencing, as 
shown in Figure 1, using the following primers (5´- 3´): TN-
F: ACCTAGATTCTACGTCAGTACT, AmpC-R: CCCTGGTAGATA-
ACGGCA, Blc-F: CATTCCTGGTTGTCGCGTGT, SugE-F: 
AGCATGGCGATACTGACGAT, SugE-R: GCCTGATATGTCCTG-
GATCGT, EcnR-R: GGATTGAGAGGGCACGAT. ISEcp1 was loca-
ted upstream blaCMY-2, and blc, sugE and ecnR were identi-
fi ed downstream (Accession number HG931731). The 
analyzed blaCMY-2 context agrees completely with the conser-
ved regions reported for Type I, II and III environments des-
cribed in S. enterica, in which blaCMY-2 gene is associated 
with the insertion sequence ISEcp1, which could enhance 
blaCMY-2 expression and mobilization
13.
Replicon type of blaCMY-2 harboring plasmid was determined 
according to Carattoli et al.2, corresponding to the IncN 
group. Plasmid size was estimated in 97 kb by PFGE analysis 
of S1 nuclease digested DNA9. Conjugation assays were 
carried out using E. coli J53 (sodic azid resistant) as 
recipient strain and Luria Bertani agar plates supplemented 
with sodium azide (150 μg/ml) and ceftadizime (10 μg/ml) 
as selection system. blaCMY-2 plasmid could not be transferred 
by conjugation in the assayed conditions. 
Multilocus sequence typing (MLST) with seven 
housekeeping genes (aroC, dnaN, hemD, hisD, purE, sucA, 
thrA) was conducted according to http://mlst.ucc.ie/mlst/
dbs/Senterica. The isolate displayed the following allelic 
profi le: 2, 7, 9, 9, 5, 9, 12, which corresponds to ST 15, as 
well as the majority of the S. Heidelberg isolates deposited 
in the MLST database. According to the S. enterica MLST 
database, ST 15 was more often reported in Europe, North 
America and Asia, however there is only one description in 
Africa and two in South America http://mlst.ucc.ie/mlst/
mlst/dbs/Senterica/.
en un hospital de la Ciudad de Buenos Aires. Se evidenció la presencia de un plásmido de 
97 kb perteneciente al grupo de incompatibilidad IncN, portador del gen blaCMY-2. ISEcp1 
fue localizado corriente arriba de blaCMY-2, promoviendo su expresión y movilización. El 
aislamiento de S. Heidelberg correspondió al secuenciotipo 15 y en la virotipifi cación se 
detectó el gen sopE. En este trabajo describimos por primera vez la producción de CMY-2 
en una cepa de S. Heidelberg en nuestro país y América Latina.
© 2014 Asociación Argentina de Microbiología. Publicado por Elsevier España, S.L. Todos 
los derechos reservados.
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Based on the ST analysis, in 2012, S. enterica isolates were 
grouped together in 138 discrete genetically related clusters 
called eBurstGroups (eBGs). Some eBGs exhibit a unique one-
to-one relationship with serovars such as eBG26 and S. 
Heidelberg (http://mlst.ucc.ie/mlst/mlst/dbs/Senterica/). 
Virotyping was performed by PCR amplifi cation of coding 
genes for proteins secreted by type III secretion systems 
(avrA, sopE), Salmonella Typhimurium genomic island CS54 
(shdA) and phage encoded genes (gogB and sb41); specifi c 
primers for invA were included as an internal control6. Among 
the virulence-related genes investigated by PCR amplifi cation, 
only sopE was detected. The sopE gene encodes for a Rho-
GTPase that induces membrane ruffl ing and elicits a pro-
infl ammatory response in epithelial cells. The cytosolic 
localization of SopE in the absence of other bacterial 
molecules is suffi cient for inducing NF-κB activation11.
Although there is a national network of laboratories that 
conducts an exhaustive surveillance of diarrheal episodes, 
reports of Salmonella spp. infections are not mandatory, 
except for S. Typhi. It is estimated that only 5% of 
salmonellosis infections are registered. According to 
national reports S. Typhimurium and S. Enteriditis constitute 
the most prevalent serotypes, being S. Heiderberg only 
sporadically reported. There are no reported data about 
extended-spectrum cephalosporin resistance among human 
S. Heidelberg isolates in Argentina. Here we report the fi rst 
CMY-2-producing S. Heiderberg human isolate in our country, 
an even in South America. 
blaCMY-2 gene, constitutes the most common marker among 
extended-spectrum cephalosporin-resistant Salmonella in 
the United States, mainly mediated by the spread of IncI1 
blaCMY-2 plasmid
1. This replicon type plasmid has also been 
described in blaCMY-2 producing S. Typhimurium isolated from 
children with diarrhea in Uruguay6. More recently IncA/C 
plasmids have been associated with blaCMY-2 bovine isolates 
of S. Heidelberg10. However, in the studied isolate blaCMY-2 
was located in an IncN plasmid, this replicon type has not 
been previously associated to blaCMY-2 in Salmonella spp. 
Even in previous studies performed in E. coli in Argentina, 
where we reported the association of blaCMY-2 with IncA/C, 
IncI1, IncFIA/FI, IncK, IncF, IncY and IncBO plasmids, the 
IncN group was not detected3,4,6.
Considering the wide diversity of Inc/blaCMY-2 associations, 
the spread of blaCMY-2 may be related to the presence of a 
transposable element responsible for its mobilization. 
Additionally, the co-mobilization of blaCMY-2 and sugE 
increases the possibility of co-selection processes. SugE is a 
member of the small multidrug resistance (SMR) transporter 
family, responsible for conferring resistance to antiseptics 
such as quaternary ammonium compounds and SDS12.
The spread of resistance markers among S. Heidelberg 
isolates constitutes a risk for the management of severe 
salmonellosis in clinical practice. Therefore, a better 
understanding of the pathogen distribution and its 
antimicrobial resistance is important for the development 
of strategies to limit salmonellosis due to multidrug-
resistant strains. 
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